ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED – Trademark Portfolio
Entity Type: 03
ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FAWLUIO. The owner is based in HONG KONG.
RM B11, 5/F, WELL TOWN IND BUILDING, NO 13 KO FAI ROAD YAU TONG
HONG KONG 999077 , HK
Showing of trademarks Trademarks
Trademark Classifications
ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED have?
ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED file in?
ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED's most well-known trademarks?
ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED's registered trademark portfolio includes well-known marks such as FAWLUIO. These are among 1 currently registered trademark in the portfolio.
What is ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED's trademark registration success rate?
ANT CLOUD CREATION E-COMMERCE HK PHARMACEUTICAL LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.